Closed incision negative pressure therapy reduces surgical site infections in vascular surgery: a prospective randomised trial (AIMS Trial). Eur J Vasc Endovasc Surg 2018; 56: 442-448.
Published: 22nd November 2018
Authors: Gombert A, Babilon M, Barbati ME, Keszei A, von Trotha KT, Jalaie H et al.
A total of 188 patients who needed a groin incision were included. The negative pressure dressing reduced surgical site infection from 33.3 to 13.2 per cent (P=0.0015), although most of these infections were superficial.Pubmed Link
You may also be interested in
A randomized clinical trial evaluating negative pressure therapy to decrease vascular groin incision complications. J Vasc Surg 2018; 68: 1744-1752.
Authors: Kwon J, Staley C, McCullough M, Goss S, Arosemena M, Abai B et al.
Management of extremity fasciotomy sites prospective randomized evaluation of two techniques. Am J Surg 2018; 216: 736–739.
Authors: Johnson LS, Chaar M, Ball CG, Perez S, Nicholas JM, Wyrzykowski AD et al.
Randomized clinical trial of negative pressure wound therapy for high-risk groin wounds in lower extremity revascularization . J Vasc Surg 2017; 66: 1814-1819.
Authors: Lee K, Murphy PB, Ingves MV, Duncan A, DeRose G, Dubois L et al.
Randomized trial of a dry-powder, fibrin sealant in vascular procedures. J Vasc Surg 2015; 62: 1288–1295.
Authors: Gupta NY, Chetter I, Hayes P, O-Yurvati AH, Moneta G, Shenov S et al.
Prospective randomized double-blinded trial comparing 2 anti-MRSA agents with supplemental coverage of cefazolin before lower extremity revascularization. Ann Surg 2015; 262: 495–501.
Authors: Stone P, AbuRahma, AF, Campbell JR, Hass S, Mousa AY et al.
A prospective randomized study of heparin-bonded graft (Propaten) versus standard graft in prosthetic arteriovenous access. J Vasc Surg 2015; 62: 115–122.
Authors: Shemesh D, Goldin I, Hijazi J, Zaghal I, Berelowitz D, Verstandig A et al. et al.
Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoroethylene graft for femoropopliteal bypass. J Vasc Surg 2015; 61: 703–712.
Authors: Lumsden AB, Morrissey NJ, Staffa R, Lindner J, Janousek L, Treska V et al.on behalf of the Comparison of Safety and Primary Patency Between the FUSION BIOLINE Heparin-Coated Vascular Graft and EXXCEL Soft ePTFE (FINEST) Trial Co-investigators et al.
Prospective, randomized, multi-institutional clinical trial of a silver alginate dressing to reduce lower extremity vascular surgery wound complications. J Vasc Surg 2015; 61: 419–427.
Authors: Ozaki CK, Hamdan AD, Barshes NR, Wyers M, Hevelone MD, Belkin M et al. et al.
A meta-analysis to compare Dacron versus polytetrafluoroethylene grafts for above-knee femoropopliteal bypass. J Vasc Surg 2014; 60: 506-515.
Authors: Rychlik IJ, Davey P, Murphy J, O'Donnell ME
Vaccuum-assisted wound closure versus alginate for the treatment of deep perivascular wound infections in the groin after vascular surgery. J Vasc Surg 2014; 59: 145-151.
Authors: Monsen C, Wann-Hansen C, Wictorsson C, Acosta S
Superior two-year results of externally unsupported polyester compared to supported grafts in above knee bypass grafting: a multicenter randomized trial. Eur J Vasc Endovasc Surg 2013; 45: 275-281.
Authors: Vriens BHR, van Det RJ, Meerwaldt R, van der Palen J, Gerrits DG, Zeebregts CJ et al. et al.
A randomised prospective multicenter trial of novel vascular sealant. Ann Vasc Surg 2012; 26: 1077–1084.
Authors: Stone WM, Cull DL, Money SR